arrow
P

Paul J. Hampel

Mayo Clinic
H指数:16
被引数:842

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia

化疗初治慢性淋巴细胞白血病患者中霍奇金淋巴瘤的转化

2026-09-260
OAAI
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions

优化惰性淋巴瘤低剂量放射治疗:比较8 Gy分2次与4 Gy分2次

2026-03-290
PRE
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience

慢性淋巴细胞白血病(CLL)患者中Richter转化的中枢神经系统受累:梅奥诊所的经验

2026-01-070
OAAI
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)

CHIP在单克隆B细胞淋巴增生病(MBL)患者中增加了患淋巴系统恶性肿瘤的风险。

2025-11-060
OAAI
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL)

基因组分析揭示了Richter transformation (RT)和chronic lymphocytic leukemia (CLL)患者中的分子异质性。

2025-11-010
OAAI
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis

高计数单克隆B细胞淋巴细胞增多症中影像学研究在预测首次治疗时间及总生存期方面的作用

2025-07-150
PRE
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study

比较年龄≥80岁慢性淋巴细胞白血病(CLL)老年患者一线疗法:一项梅奥诊所与丹麦全国性研究

2025-06-180
PRE
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

未接受过既往化疗免疫疗法治疗的Richter转化CLL患者的结局

2025-02-201
OA
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism
2025-01-010
PRE
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era
LEUKEMIA
IF13.4
2024-12-100
PRE
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)

单克隆b细胞淋巴细胞增多症 (MBL) 患者的镶嵌染色体改变 (mCAs)

2024-11-060
OAAI
Hodgkin Lymphoma Transformation in Patients Who Received No Prior Chemotherapy for CLL/SLL: Outcomes from a Multicenter Retrospective Study in the Modern Era of Therapy

霍奇金淋巴瘤转化:在接受过无既往化疗的CLL/SLL患者中的转化结局——来自现代治疗时代的多中心回顾性研究

BLOOD
IF23.1
2024-11-050
PRE
Can I Cap the Prednisone? a Systematic Review and Meta-Analysis Comparing Fixed-Dose with Body Surface Area (BSA)-Adjusted Prednisone in Untreated Diffuse Large B-Cell Lymphoma (DLBCL)

我可以限制泼尼松的剂量吗?一项系统评价和Meta分析,比较固定剂量与体表面积(BSA)调整的泼尼松在未治疗的弥漫性大B细胞淋巴瘤(DLBCL)中的差异。

BLOOD
IF23.1
2024-11-050
PRE
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
LEUKEMIA
IF13.4
2024-06-084
OAAI
Arti fi cial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia
2024-04-012
OA
T-cell receptor repertoire changes associated with clinical response in patients with B-cell non-Hodgkin's lymphoma receiving CD19 CAR-T therapy
2024-03-221
PRE
Monocyte transcriptome profiles associated with clinical response in patients with B-cell non-Hodgkin's lymphoma receiving CD19-directed CAR-T therapy
2024-03-220
PRE